Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster

被引：5
|
作者：
Wagenhauser, Isabell [1 ,2 ]
Reusch, Julia [1 ,2 ]
Gabel, Alexander [1 ]
Krone, Lukas B. [3 ,4 ]
Kurzai, Oliver [5 ,6 ]
Petri, Nils [2 ]
Krone, Manuel [1 ,5 ,7 ]
机构：
[1] Univ Hosp Wurzburg, Infect Control & Antimicrobial Stewardship Unit, Wurzburg, Germany
[2] Univ Hosp Wurzburg, Dept Internal Medi 1, Wurzburg, Germany
[3] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England
[4] Univ Bern, Univ Hosp Psychiat & Psychotherapy, Bern, Switzerland
[5] Julius Maximilians Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany
[6] Leibniz Inst Nat Prod Res, Infect Biologye Hans Knoell Inst, Jena, Germany
[7] Univ Hosp Wuerzburg, Infect Control & Antimicrobial Stewardship Unit, Josef-Schneider Str 2-E1, D-97080 Wurzburg, Germany
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2023年 / 29卷 / 04期
关键词：
D O I：
10.1016/j.cmi.2023.01.008
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：554 / 556
页数：3
相关论文
共 50 条
  • [21] Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial
    Okada, Yusuke
    Kumagai, Yuji
    Okura, Iori
    Otsuki, Mako
    Ishida, Natsuki
    Iwama, Yasuhiro
    Minamida, Takeshi
    Yagi, Yukihiro
    Kurosawa, Toru
    van Boxmeer, Josephine
    Zhang, Ye
    Smolenov, Igor
    Walson, Judd L.
    LANCET INFECTIOUS DISEASES, 2025, 25 (03): : 290 - 300
  • [22] Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273
    Ailsworth, Samuel M.
    Keshavarz, Behnam
    Richards, Nathan E.
    Workman, Lisa J.
    Murphy, Deborah D.
    Nelson, Michael R.
    Platts-Mills, Thomas A. E.
    Wilson, Jeffrey M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (01) : 67 - 73
  • [23] Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
    Cheng, Samuel M. S.
    Mok, Chris K. P.
    Li, John K. C.
    Chan, Ken K. P.
    Luk, Kristine S.
    Lee, Ben H. W.
    Gu, Haogao
    Chan, Karl C. K.
    Tsang, Leo C. H.
    Yiu, Karen Y. S.
    Ling, Ken K. C.
    Tang, Yun Sang
    Luk, Leo L. H.
    Yu, Jennifer K. M.
    Pekosz, Andrew
    Webby, Richard J.
    Cowling, Benjamin J.
    Hui, David S. C.
    Peiris, Malik
    VIROLOGY JOURNAL, 2024, 21 (01)
  • [24] Hemophagocytic Lymphohistiocytosis Following BNT162b2 mRNA COVID-19 Vaccination
    Lin, Ting-Yu
    Yeh, Yun-Hsuan
    Chen, Li-Wen
    Cheng, Chao-Neng
    Chang, Chen
    Roan, Jun-Neng
    Shen, Ching-Fen
    VACCINES, 2022, 10 (04)
  • [25] Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
    Samuel M.S. Cheng
    Chris K.P. Mok
    John K.C. Li
    Ken K.P. Chan
    Kristine S. Luk
    Ben H.W. Lee
    Haogao Gu
    Karl C.K. Chan
    Leo C.H. Tsang
    Karen Y.S. Yiu
    Ken K.C. Ling
    Yun Sang Tang
    Leo L.H. Luk
    Jennifer K.M. Yu
    Andrew Pekosz
    Richard J. Webby
    Benjamin J. Cowling
    David S.C. Hui
    Malik Peiris
    Virology Journal, 21
  • [26] Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study
    Yechezkel, Matan
    Mofaz, Merav
    Painsky, Amichai
    Patalon, Tal
    Gazit, Sivan
    Shmueli, Erez
    Yamin, Dan
    LANCET RESPIRATORY MEDICINE, 2023, 11 (02): : 139 - 150
  • [27] Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine
    Azzi, Lorenzo
    Dalla Gasperina, Daniela
    Veronesi, Giovanni
    Shallak, Mariam
    Maurino, Vittorio
    Baj, Andreina
    Gianfagna, Francesco
    Cavallo, Pierpaolo
    Dentali, Francesco
    Tettamanti, Lucia
    Maggi, Fabrizio
    Maffioli, Lorenzo Stefano
    Tagliabue, Angelo
    Accolla, Roberto Sergio
    Forlani, Greta
    EBIOMEDICINE, 2023, 88
  • [28] Acute hepatitis following mRNA BNT162b2 COVID-19 vaccination
    Cheah, Matthew
    Girgis, Safwat
    Bain, Vincent G.
    CANADIAN LIVER JOURNAL, 2022, 5 (04): : 535 - 539
  • [29] BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study
    Bieber, Amir
    Sagy, Iftach
    Novack, Lena
    Brikman, Shay
    Abuhasira, Ran
    Ayalon, Snait
    Novofastovski, Irina
    Abu-Shakra, Mahmoud
    Mader, Reuven
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (07) : 1028 - 1035
  • [30] Short-Term Safety of Booster Immunization With BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers
    Paran, Yael
    Saiag, Esther
    Spitzer, Avishay
    Angel, Yoel
    Yakubovsky, Michal
    Padova, Hagit
    Ben-Ami, Ronen
    Goldinger, Ilana
    Gamzu, Ronni
    Sprecher, Eli
    Zeltser, David
    Henig, Oryan
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03):
12345